Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Development and commercialization of a semi-supervised learning AI for robust diagnosis in real world settings.

Descrizione del progetto

Computer per diagnosticare come i medici umani

Il potenziale dell’intelligenza artificiale nell’assistenza sanitaria sta crescendo. Quando si tratta di fare diagnosi mediche, i computer potrebbero avere lo stesso successo dei medici umani. Il progetto MrDoc, finanziato dall’UE, ha sviluppato una piattaforma di apprendimento artificiale semi-supervisionata in grado di analizzare e interpretare set di dati medici. Ha progettato un processo che imita l’immaginazione umana creativa per rilevare e diagnosticare rapidamente alcune malattie non trasmissibili quali le malattie cardiovascolari e il diabete, utilizzando parametri biometrici (pressione arteriosa, variabilità della frequenza cardiaca, emoglobina, glicemia) con un alto livello di precisione. Il progetto si sta preparando per il mercato, per vendere e concedere in licenza la sua soluzione a tre gruppi target: pazienti, sviluppatori di strumenti software e hardware (nonché App) e aziende farmaceutiche.

Obiettivo

Non-communicable diseases such as cardiovascular diseases, diabetes, are by far the leading cause of death in the world and a growing burden for patients, healthcare providers and local economies. Despite many NCDs conditions like cardiac arrhythmia, diabetes, hypertension can be cured with early detection, they don’t often show symptoms. During their medical check-up, medical practitioners (GP) can’t be accurate as specific examinations (e.g. EGCs, blood tests), resulting in a growing number of errors or false negative/positive, which represent for Healthcare systems and additional financial burden. People are usually discouraged from doing specific examination due to long waiting time, invasiveness of medical tests and additional costs.Even if technological advancements have led to AI based easy-to-use solutions able to contribute positively to easy and early detection of diseases and pre-diseases condition, they come along with many significant limitations, such as the need to train on huge amounts of labelled data and difficulties in managing inputs that are noisy, incomplete or simply different from the original dataset (such data generated from a smartphone camera).This results in limited accuracy or significant costs and time consume for labelling of data. We have developed a platform based on a semi-supervised learning AI, able to analyse and interpret medical dataset through a process that mimics human creative imagination and, in a very short timeframe, detect and diagnose some NCDs and biometric parameters (blood pressure, Heart rate variability, haemoglobin, blood glucose) from “dirty” signals, generated by consumer electronics devices (smartphones, closed circuit cameras, etc.), with a high level of accuracy overcoming existing limitations.We aim at selling and licence our solution to 3 main targets: - final consumers/patients, - producers/owners of software and hardware tools (as well as Apps) in Health sector, Pharmaceutical companies.

Programma(i)

Argomento(i)

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-EIC-SMEInst-2018-2020

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

MR DOC SRL
Contributo netto dell'UE
€ 50 000,00
Indirizzo
VIA PIETRO BLASERNA 40
00146 ROMA
Italia
PMI
Sì
Regione
Centro (IT) Lazio Roma
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00